Sandoz Inc. has rolled out lansoprazole capsules, amoxicillin capsules and clarithromycin tablets, a generic version of the combination medicine Prevpac from Takeda Pharmaceuticals.


Sandoz, lansoprazole capsules, amoxicillin capsules, clarithromycin tablets, Prevpac, generic version, combination medicine, Takeda Pharmaceuticals, Novartis, Peter Goldschmidt, H. pylori infection, duodenal ulcer disease


































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Sandoz launches generic version of Prevpac

March 28th, 2014

PRINCETON, N.J. – Sandoz Inc. has rolled out lansoprazole capsules, amoxicillin capsules and clarithromycin tablets, a generic version of the combination medicine Prevpac from Takeda Pharmaceuticals.

The Novartis subsidiary said Thursday that it's marketing its generic product in the same strengths as are marketed for Prevpac.

The combo medication is indicated for the eradication of H. pylori infection in patients with duodenal ulcer disease. It encompasses amoxicillin and clarithromycin, which are antibiotics, and lansoprazole, a proton pump inhibitor that helps decrease production of excess stomach acid.

"Sandoz is proud to provide a generic version of this important gastrointestinal therapy," Peter Goldschmidt, president of Sandoz, said in a statement. "This launch further expands the Sandoz offering of affordable, high-quality medicines."

U.S. sales for branded combination of lansoprazole capsules, amoxicillin capsules and clarithromycin tablets totaled about $69.7 million for the 12 months ended in January, according to IMS Health data reported by Sandoz.

Advertisement